Literature DB >> 11821164

Evaluation of the VTEC-Screen "Seiken" test for detection of different types of Shiga toxin (verotoxin)-producing Escherichia coli (STEC) in human stool samples.

Lothar Beutin1, Sonja Zimmermann, Kerstin Gleier.   

Abstract

An immunoassay for in vitro detection of Shiga (Vero) toxins Stx1 and Stx2 (VTEC-Screen "Seiken") was compared with the verocell toxicity test (VCA) and an stx-gene specific PCR for detection of Shiga toxin-producing E. coli (STEC) from 234 human stool samples selectively enriched on sorbitol-MacConkey (SMAC) agar. Culturable STEC were isolated from 59 (25.2%) of the 234 stool specimens and were found to be distributed over 20 different O-serogroups. Fifty-three (89.8%) of the 59 STEC-positive samples were identified with the VTEC-Screen compared to 55 (93.2%) with the PCR and 58 (98.3%) with the VCA. A possible false positive reaction with the VTEC-Screen was obtained with one sample and five samples showed aspecific reactions with both the test- and the control latex. The VTEC-Screen detected all samples which contained Stx1 producing strains (77.9% of STEC-positive samples) but was negative with six samples (10.2%) which contained Stx2 and/or Stx2 variant producers, although secondary enrichment of on brain-heart infusion agar detected three of these to improve the detection rate to 94.9%. Examination of reference strains encoding different genotypes of stx(1) and stx(2) indicated that certain variants of Stx2 reacted poorly (Stx2d-Ount, Stx2e and Stx2ev) or not at all with the VTEC-Screen. Overall, however, the test was found to be accurate, rapid and easy to perform, thus being suitable for the routine screening of clinical stool specimens for STEC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821164     DOI: 10.1016/s0732-8893(01)00325-x

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  Comparison of a commercial reversed passive latex agglutination assay to an enzyme immunoassay for the detection of Shiga toxin-producing Escherichia coli.

Authors:  K C Carroll; K Adamson; K Korgenski; A Croft; R Hankemeier; J Daly; C H Park
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-23       Impact factor: 3.267

2.  Role of the laboratory in the diagnosis of enterohemorrhagic Escherichia coli infections.

Authors:  Sue C Kehl
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

3.  Specificity of PCR and serological assays in the detection of Escherichia coli Shiga toxin subtypes.

Authors:  Peter C H Feng; Karen Jinneman; Flemming Scheutz; Steven R Monday
Journal:  Appl Environ Microbiol       Date:  2011-07-29       Impact factor: 4.792

4.  Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period.

Authors:  Lothar Beutin; Gladys Krause; Sonja Zimmermann; Stefan Kaulfuss; Kerstin Gleier
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

5.  Prevalence and characteristics of Shiga toxin-producing Escherichia coli (STEC) from cattle in Korea between 2010 and 2011.

Authors:  Eun Kang; Sun Young Hwang; Ka Hee Kwon; Ki Yeon Kim; Jae Hong Kim; Yong Ho Park
Journal:  J Vet Sci       Date:  2013-06-30       Impact factor: 1.672

Review 6.  Diarrheagenic Escherichia coli.

Authors:  Tânia A T Gomes; Waldir P Elias; Isabel C A Scaletsky; Beatriz E C Guth; Juliana F Rodrigues; Roxane M F Piazza; Luís C S Ferreira; Marina B Martinez
Journal:  Braz J Microbiol       Date:  2016-11-05       Impact factor: 2.476

7.  Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities.

Authors:  Letícia B Rocha; Daniela E Luz; Claudia T P Moraes; Andressa Caravelli; Irene Fernandes; Beatriz E C Guth; Denise S P Q Horton; Roxane M F Piazza
Journal:  Toxins (Basel)       Date:  2012-09-18       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.